The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial
Abstract
As part of the Monoclonal Anti-TNF: A Randomized Controlled Sepsis (MONARCS) trial, which enrolled patients with suspected sepsis, we sought to determine whether adequate antibiotic therapy was associated with a decreased mortality rate. The study enrolled 2634 patients, 91% of whom received adequate antibiotic therapy. The mortality rate among patients given adequate antibiotic treatment was 33%, versus 43% among patients given inadequate treatment (P<.001). We conclude that adequate antibiotic therapy results in a significant decrease in the crude mortality rate among patients suspected of sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228
Brun-Buisson, C. (1995) · JAMA · doi:10.1001/jama.1995.03530120060042 · Cited by 772
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.
Bone, R. C., Fisher, C. J., Clemmer, T. P., Gj, S., METZ, C. A., & BALK, R. A. (1989) · PubMed · Cited by 689
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik, & Pitlik (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00379.x · Cited by 685
Sepsis syndrome: A valid clinical entity
BONE, R. C., FISHER, C. J., CLEMMER, T. P., SLOTMAN, G. J., METZ, C. A., & BALK, R. A. (1989) · Critical Care Medicine · doi:10.1097/00003246-198905000-00002 · Cited by 537
McGowan, J. E., Barnes, M. W., & Finland, M. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/132.3.316 · Cited by 498
Outcome of intensive care patients in a group of British intensive care units
Goldhill, D. R., & Sumner, A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199808000-00017 · Cited by 327
Byl, B., Clevenbergh, P., Jacobs, F., Struelens, M. J., Zech, F., Kentos, A., & Thys, J. (1999) · Clinical Infectious Diseases · doi:10.1086/520182 · Cited by 266
A Three-Year Study of Positive Blood Cultures, with Emphasis on Prognosis
Roberts, F. J., Greere, I. W., & Coldman, A. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.34 · Cited by 186
Long-term Survival Following Bacteremia or Fungemia
Leibovici, L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530100047033 · Cited by 166
Cited by
Annane, D., Bellissant, E., & Cavaillon, J.-M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17667-8 · Cited by 1,213
Kumar, A., Ellis, P., Arabi, Y., Roberts, D., Light, B., Parrillo, J. E., Dodek, P., Wood, G., Kumar, A., Simon, D., et al. (2009) · Chest · doi:10.1378/chest.09-0087 · Cited by 1,187
Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu027 · Cited by 1,090
Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70036-2 · Cited by 1,046
Ferrer, R. (2008) · JAMA · doi:10.1001/jama.299.19.2294 · Cited by 741
Antimicrobial Stewardship Programs in Health Care Systems
MacDougall, C., & Polk, R. E. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.638-656.2005 · Cited by 705
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.760-766.2005 · Cited by 692
Nguyen, H. B., Corbett, S. W., Steele, R., Banta, J., Clark, R. T., Hayes, S. R., Edwards, J., Cho, T. W., & Wittlake, W. A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000259463.33848.3d · Cited by 555
Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study.
Ferrer, R., Artigas, A., Suarez, D., Palencia, E., Levy, M. M., Arenzana, A., Pérez, X. L., & Sirvent, J.-M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1912oc · Cited by 433
Gram-positive toxic shock syndromes
Lappin, E., & Ferguson, A. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70066-0 · Cited by 433
Augmented Renal Clearance: Implications for Antibacterial Dosing in the Critically Ill
Udy, A. A., Roberts, J. A., Boots, R. J., Paterson, D. L., & Lipman, J. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318140-000000000-00000 · Cited by 377
Exotoxins and endotoxins: Inducers of inflammatory cytokines
Cavaillon, J.-M. (2018) · Toxicon · doi:10.1016/j.toxicon.2017.10.016 · Cited by 346
Lodise, T. P., Patel, N., Kwa, A., Graves, J., Furuno, J. P., Graffunder, E., Lomaestro, B., & McGregor, J. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00338-07 · Cited by 318
Roberts, J. A., & Lipman, J. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645080-00001 · Cited by 283
Roimi, M., Neuberger, A., Shrot, A., Paul, M., Geffen, Y., & Bar-Lavie, Y. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05876-8 · Cited by 91
Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
Lepak, A., & Andes, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.001 · Cited by 62
Tansarli, G. S., Andreatos, N., Pliakos, E. E., & Mylonakis, E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02495-18 · Cited by 56
Metadata
- Authors
- MacArthur, R. D., Miller, M., Albertson, T., Panacek, E., Johnson, D., Teoh, L., & Barchuk, W.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-15
- Volume
- 38
- Issue
- 2
- Pages
- 284-288
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2106443705
- Cited by
- 271
- References
- 13
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.